While not upregulated on all tumors, oncologic lineages with increased CD73 expression have a degree of protection against eATP, proinflammatory cytokines, and tumor-killing immune cells; this, in turn, conveys a worse prognosis for the patient with some forms of cancer (Roh et al., 2020). Here, NT5E is linked to neoplasm.